BioWorld

July 3, 2003

Human Stem Cells Near To Spinal Cord Helped Rat Hind Limb Work In Model Of Lou Gehrig's Disease

ICOS, Lilly Finish Cialis NDA; FDA Accepts Additional Data

Holiday Notice

The BioWorld offices will be closed Friday in observance of Independence Day in the U.S. No issue will be published that day. The next issue of BioWorld Today will be dated Monday, July 7. Read More

Endo's Largest Shareholder Selling Stock Worth $232.5M

Other News To Note

Gilead's Antiretroviral Emtriva Receives FDA Approval In HIV

HIV patients gained another treatment option yesterday as the FDA signed off on Emtriva, a once-daily capsule for HIV from Gilead Sciences Inc. (BioWorld Today) Read More

Invitrogen Paying $325M In Cash To Acquire Molecular Probes Inc.

Today's news in brief

BioWorld

BioWorld briefs for June 15, 2026.

Ethyreal launches to treat the underlying cause of Graves’, TED

BioWorld

Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...

Microbiota modulates the antidepressant effects of GLP-1 analogues

BioWorld Science

Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...

Microscopic image of chronic myeloid leukemia

Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid

BioWorld

Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...

EHA 2026: With new lenses, a changing view on pediatric cancers

BioWorld

In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...